Wortmannin is a potent phosphatidylinositol 3-kinase inhibitor: the role of phosphatidylinositol 3,4,5-trisphosphate in neutrophil responses - PubMed (original) (raw)
Wortmannin is a potent phosphatidylinositol 3-kinase inhibitor: the role of phosphatidylinositol 3,4,5-trisphosphate in neutrophil responses
A Arcaro et al. Biochem J. 1993.
Abstract
Phosphatidylinositol 3,4,5-trisphosphate (PtdInsP3) is rapidly produced upon exposure of neutrophils to the chemoattractant N-formylmethionyl-leucylphenylalanine (fMLP), and has been proposed to act as a second messenger mediating actin polymerization and respiratory-burst activity. Here we present evidence that wortmannin, a known inhibitor of respiratory-burst activity, acts on PtdIns 3-kinase, the enzyme producing PtdInsP3 from PtdIns(4,5)P2. Pretreatment of 32P-labelled human neutrophils with 100 nM wortmannin totally abolished fMLP-mediated PtdInsP3 production, raised PtdInsP2 levels, and did not affect cellular PtdInsP and PtdIns contents. The inhibitory effect on PtdInsP3 formation in intact cells was dose-dependent, with an IC50 of approximately 5 nM. Similar results were obtained with PtdIns 3-kinase immunoprecipitated by antibodies against the p85 regulatory subunit: wortmannin totally inhibited PtdIns3P production in immunoprecipitates at concentrations of 10-100 nM (IC50 approximately 1 nM). These results illustrate the direct and specific inhibition of PtdIns 3-kinase by wortmannin. Since agonist-mediated respiratory-burst activation is most sensitive to wortmannin (IC50 = 12 nM), this suggests that agonist-mediated PtdInsP3 formation is indispensable for this cell response. Neutrophils pretreated with wortmannin develop oscillatory changes in F-actin content, but actin polymerization in response to fMLP is not inhibited. This, and the absence of PtdInsP3 under these conditions, are in agreement with a modulatory role for PtdInsP3 in cytoskeletal rearrangements, but imply that PtdInsP3 production is not a primary event triggering elongation of actin filaments in neutrophils.
Similar articles
- Platelet-derived growth factor-induced phosphatidylinositol 3-kinase activation mediates actin rearrangements in fibroblasts.
Wymann M, Arcaro A. Wymann M, et al. Biochem J. 1994 Mar 15;298 Pt 3(Pt 3):517-20. doi: 10.1042/bj2980517. Biochem J. 1994. PMID: 8141762 Free PMC article. - Inhibition of neutrophil oxidative burst and granule secretion by wortmannin: potential role of MAP kinase and renaturable kinases.
Sue-A-Quan AK, Fialkow L, Vlahos CJ, Schelm JA, Grinstein S, Butler J, Downey GP. Sue-A-Quan AK, et al. J Cell Physiol. 1997 Jul;172(1):94-108. doi: 10.1002/(SICI)1097-4652(199707)172:1<94::AID-JCP11>3.0.CO;2-O. J Cell Physiol. 1997. PMID: 9207930 - Wortmannin as a unique probe for an intracellular signalling protein, phosphoinositide 3-kinase.
Ui M, Okada T, Hazeki K, Hazeki O. Ui M, et al. Trends Biochem Sci. 1995 Aug;20(8):303-7. doi: 10.1016/s0968-0004(00)89056-8. Trends Biochem Sci. 1995. PMID: 7667888 Review. - Lipids on the move: phosphoinositide 3-kinases in leukocyte function.
Wymann MP, Sozzani S, Altruda F, Mantovani A, Hirsch E. Wymann MP, et al. Immunol Today. 2000 Jun;21(6):260-4. doi: 10.1016/s0167-5699(00)01649-2. Immunol Today. 2000. PMID: 10939787 Review. No abstract available.
Cited by
- Clemastine and hyperthermia enhance sensitization of osteosarcoma cells for apoptosis.
Obu S, Niture S, Hoang H, Gadi S, Vandana, He Y, Kumar D. Obu S, et al. Mol Cell Oncol. 2024 May 14;11(1):2351622. doi: 10.1080/23723556.2024.2351622. eCollection 2024. Mol Cell Oncol. 2024. PMID: 38778919 Free PMC article. - GKT137831 and hydrogen peroxide increase the release of 6-nitrodopamine from the human umbilical artery, rat-isolated right atrium, and rat-isolated vas deferens.
Britto-Júnior J, Furlaneto R, Lima AT, de Oliveira MG, Severino B, Frecentese F, Fiorino F, Caliendo G, Muscará MN, De Nucci G. Britto-Júnior J, et al. Front Pharmacol. 2024 Apr 5;15:1348876. doi: 10.3389/fphar.2024.1348876. eCollection 2024. Front Pharmacol. 2024. PMID: 38645555 Free PMC article. - A Long Way to Go: A Scenario for Clinical Trials of PI3K Inhibitors in Treating Cancer.
Trigueiros BAFDS, Santos IJS, Pimenta FP, Ávila AR. Trigueiros BAFDS, et al. Cancer Control. 2024 Jan-Dec;31:10732748241238047. doi: 10.1177/10732748241238047. Cancer Control. 2024. PMID: 38494880 Free PMC article. - Thrombolytic therapy based on lyophilized platelet-derived nanocarriers for ischemic stroke.
Migliavacca M, Correa-Paz C, Pérez-Mato M, Bielawski PB, Zhang I, Marie P, Hervella P, Rubio M, Maysinger D, Vivien D, Del Pino P, Pelaz B, Polo E, Campos F. Migliavacca M, et al. J Nanobiotechnology. 2024 Jan 3;22(1):10. doi: 10.1186/s12951-023-02206-5. J Nanobiotechnology. 2024. PMID: 38166940 Free PMC article. - Plasma membrane nanodeformations promote actin polymerization through CIP4/CDC42 recruitment and regulate type II IFN signaling.
Ledoux B, Zanin N, Yang J, Mercier V, Coster C, Dupont-Gillain C, Alsteens D, Morsomme P, Renard HF. Ledoux B, et al. Sci Adv. 2023 Dec 15;9(50):eade1660. doi: 10.1126/sciadv.ade1660. Epub 2023 Dec 13. Sci Adv. 2023. PMID: 38091386 Free PMC article.
References
- Biochem Biophys Res Commun. 1990 Apr 16;168(1):320-7 - PubMed
- Trends Biochem Sci. 1993 Feb;18(2):43-7 - PubMed
- J Cell Biol. 1990 Jun;110(6):1983-91 - PubMed
- J Biol Chem. 1990 Oct 5;265(28):16725-8 - PubMed
- J Biol Chem. 1990 Nov 15;265(32):19704-11 - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources